July 10, 2025 Hospital Services – Coverage of Gene Therapies for Sickle Cell Disease LAC 50:V.120
Baton Rouge, Louisiana, - Hospital Services – Coverage of Gene Therapies for Sickle Cell Disease LAC 50:V.120
Continues the July 1, 2025 Emergency Rule which adopted cell and gene therapy model that provides additional supplemental and federal rebates for gene therapies for sickle cell disease.
Contact Information: Kimberly Sullivan, Bureau of Health Services Financing, P.O. Box 91030, Baton Rouge, LA 70821-9030
Disclaimer: Please note that the official versions of the Notices of Intent are maintained by the Office of State Register’s website at http://www.doa.louisiana.gov/osr/osr.htm. The excerpted versions of these Notices of Intent contained on this website are provided as a courtesy service to the public and is unofficial and should not be regarded as such. Users are encouraged to visit the Office of State Register’s website for the official version.
Emergency Rule
July 1, 2025
Notice of Intent
Prior to Proposed Rule: N/A